Որոնման արդյունքները - V.A. Merkulov

Good Pharmacovigilance Practice in the United States and the European Union ‌ V. A. Merkulov, N. D. Bunyatyan, A. P. Pereverzev

Connect to this object online.

FEATURES OF QUALITY CONTROL STRATEGY FOR DRUGS BASED ON VIABLE SKIN CELLS ‌ O. A. Rachinskaya, E. V. Melnikova, V. A. Merkulov

Connect to this object online.

The distribution of fullerene n anoparticles in the body in preclinical studies ‌ R. N. Alyautdin, B. K. Romanov, V. A. Merkulov

Connect to this object online.

The revision of the restrictive lists of medicinal products ‌ B. K. Romanov, Yu. V. Olefir, V. A. Merkulov, Y. O. Pegova

Connect to this object online.

STUDY OF NEUROVIRULENT PROPERTIES OF VACCINE AGAINST CULTURAL LIVE RUBELLA ‌ A.N. Mironov, A.A. Tsaan, D.S. Bushmenkov, A.A. Romanova, V.A. Merkulov, N.N. Stepanov

Connect to this object online.

STUDY OF NEUROVIRULENT PROPERTIES OF VACCINE AGAINST CULTURAL LIVE RUBELLA ‌ A.N. Mironov, A.A. Tsaan, D.S. Bushmenkov, A.A. Romanova, V.A. Merkulov, N.N. Stepanov

Connect to this object online.

Nanoparticle albumin-bound paclitaxel - first step of nanotechnology into clinical practice ‌ R. N. Alyautdin, B. K. Romanov, В. К. Лепахин, N. D. Bunyatyan, V. A. Merkulov, A. N. Mironov

Connect to this object online.

RISK ASSESSMENT OF ADVANCED THERAPY MEDICINAL PRODUCTS ‌ R. N. Alyautdin, B. K. Romanov, A. N. Yavorsky, N. D. Bunyatyan, V. A. Merkulov, A. N. Mironov

Connect to this object online.

Nanoscale Therapeutic System: Safety Assessment Features ‌ E. M. Bovina, B. K. Romanov, A. S. Kazakov, N. Yu. Velts, E. O. Zhuravleva, T. M. Bukatina, R. N. Alyautdin, V. A. Merkulov

Connect to this object online.

EVALUATIONS OF ADVERSE DRUGS REACTIONS IN RUSSIA IN 2013 ‌ V. A. Merkulov, N. D. Bunyatyan, V. K. Lepakhin, B. K. Romanov, I. A. Toropova, E. Y. Kolesnikova, N. A. Ozeretskovsky, S. G. Alexina

Connect to this object online.